Visgenx: Funding, Investors & Team (Oct 2026)
Visgenx focuses on creating treatments to safeguard against vision impairment caused by retinal disorders. The company's initiatives revolve around enhancing the activity of a particular gene called ELOVL2, which has the potential to regulate the aging process in cells crucial for maintaining proper vision.
Visgenx has raised $2.8M across 1 funding round on record, the most recent an undisclosed round of $2.8M announced in Jun 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Visgenx Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Visgenx Funding Rounds
Visgenx Founders and Leadership Team
No contact details are on record for this team yet.
Visgenx Funding Compared to Other Biotechnology Startups
Visgenx's latest round of $2.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Visgenx in Biotechnology and San Diego
Companies Similar to Visgenx
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Visgenx Funding FAQs
What does Visgenx do?
Visgenx focuses on creating treatments to safeguard against vision impairment caused by retinal disorders. The company's initiatives revolve around enhancing the activity of a particular gene called ELOVL2, which has the potential to regulate the aging process in cells crucial for maintaining proper vision.
How much funding has Visgenx raised?
Visgenx has raised $2.8M across 1 round on record. The most recent is an undisclosed round of $2.8M announced in Jun 2023.
When did Visgenx last raise funding?
Visgenx's most recent funding round on record is an undisclosed round of $2.8M, announced in Jun 2023.
Who founded Visgenx?
FundedIQ lists Daniel L Chao (Founder) at Visgenx.
Where is Visgenx headquartered?
Visgenx is based in San Diego, California, United States.
How many employees does Visgenx have?
Visgenx is in the 1-10 employee band.
How does Visgenx's funding compare to other Biotechnology startups?
Visgenx's latest round of $2.8M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Visgenx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Visgenx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.